ASHG 2015 Tipsheet: Neurogenetics and Mental Health Research

Media Contact:
Nalini Padmanabhan
ASHG Communications Manager

For Immediate Release
Friday, September 18, 2015
12:00 pm U.S. Pacific Time (UTC-05:00)


Tuesday through Saturday, Oct. 6-10, 2015


American Society of Human Genetics 2015 Annual Meeting

Baltimore Convention Center, 1 West Pratt Street, Baltimore, MD 21201


Invited and platform (oral) sessions and other presentations of the latest research into neurogenetics, mental health, and intellectual disability:

Wednesday, Oct. 7, 11:00 am-1:00 pm, Room 307
Invited Session: Mendelian disorders of the epigenetic machinery: Genetic disorders with epigenetic consequences

Moderators: Hans T. Bjornsson, Johns Hopkins University; and Sharon E. Smith, Boston Children’s Hospital

  • 11:00-11:30 am: Kabuki syndrome: A potentially treatable cause of intellectual disability
    H. T. Bjornsson, Johns Hopkins University
  • 12:00-12:30 pm: MBD5-associated intellectual disability: A methyl-binding protein that regulates target gene expression affecting circadian, developmental, and neurological pathways
    S. H. Elsea, Baylor College of Medicine
  • 12:30-1:00 pm: Defects of the maintenance methyltransferase DNMT1 lead to progressive neurological phenotypes in association with global hypomethylation
    C. Klein, Mayo Clinic

Wednesday, Oct. 7, 11:00 am-1:00 pm, Room 327
Invited Session: Epilepsy genetics: Exomes, mechanisms, and interventions
Moderators: Miriam H. Meisler, University of Michigan, Ann Arbor; and Heather C. Mefford, University of Washington

Wednesday, Oct. 7, 2:30-4:30 pm, Hilton Ballroom 1
Platform Session: Recent advances in the genetic basis of neuromuscular and other neurodegenerative phenotypes
Moderator(s): Megan Dennis, UC Davis; and Marina Kennerson, ANZAC Research Institute

Wednesday, Oct. 7, 2:30-4:30 pm, Hilton Ballroom 4
Platform Session: Neuropsychiatric diseases of childhood
Moderator(s): Peristera Paschou, Democritus University of Thrace; and Jennifer Mulle, Emory University

Thursday, Oct. 8, 7:15-8:45 am, Room 337
Invited Workshop: Clinical applications of psychiatric genomics
Pre-registration ($25) is required to attend this event.

Thursday, Oct. 8, 2:30-4:30 pm, Room 316
Platform Session: Adult-onset neuropsychiatric disease
Moderator(s): Dan Arking, Johns Hopkins University; and Nora Urraca, Le Bonheur Children’s Hospital

Thursday, Oct. 8, 5:15-5:30 pm, Hilton Ballroom 4
Platform Presentation: Discovery of novel dominant and recessive causes of severe developmental disorders, in coding and non-coding sequences
M. Hurles, Wellcome Trust Sanger Institute, et al

Friday, Oct. 9, 9:00-9:30 am, Hall F
2015 William Allan Award Presentation: Kay Davies, DPhil
Dr. Davies led early research into Duchenne Muscular Dystrophy, and her laboratory currently studies other neurogenetic diseases, such as schizophrenia and ALS.

Friday, Oct. 9, 2:15-4:15 pm, Room 307
Platform Session: New genes and mechanisms in developmental disorders and intellectual disabilities
Moderator(s): Donna Martin, University of Michigan, Ann Arbor; and Heather C. Mefford, University of Washington

Friday, Oct. 9, 4:00-4:15 pm, Ballroom I
Platform Presentation: The next wave of autism gene discovery by targeted sequencing of thousands of patients
H. Stessman, University of Washington, et al

Friday, Oct. 9, 4:30-6:30 pm, Room 309
Platform Session: New thoughts about neurodevelopment and intellectual disability
Moderator(s): Lauren Weiss, UCSF; and Michael Gambello, Emory University

Friday, Oct. 9, 4:30-6:30 pm, Room 316
Platform Session: Schizophrenia and brain development
Moderator(s): Loyal Goff, Johns Hopkins University; and Karyn Meltz Steinberg, Washington University Genome Center

Friday, Oct. 9, 4:45-5:00 pm, Room 307
Platform Presentation: Novel genetic modifiers of retinitis pigmentosa identified by exploiting natural variation in Drosophila
C. Y. Chow, Cornell University, et al

Friday, Oct. 9, 5:15-5:30 pm, Room 307
Platform Presentation: The molecular pathology of a large cohort of individuals with inherited retinal disease, determined through whole genome sequencing
K. J. Carss, University of Cambridge, et al

Saturday, Oct. 10, 10:30 am-12:30 pm, Hilton Ballroom 4
Platform Session: Intellectual ability and disability
Moderator(s): Alicio Smith, Emory University; and Adam Locke, University of Michigan

Saturday, Oct. 10, 10:45-11:00 am, Ballroom I
Platform Presentation: Genome sequencing of autism families reveals disruption in non-coding regulatory DNA
T. N. Turner, University of Washington, et al

Saturday, Oct. 10, 1:45-2:15 pm, Ballroom III
Invited Session Presentation: Treating dominantly inherited brain diseases
B. L. Davidson, Children’s Hospital of Philadelphia

Ongoing: Posters Open for Viewing, Exhibit Hall

Molecular Basis of Mendelian Disorders, Posters 2795-3025

Psychiatric Genetics, Neurogenetics and Neurodegeneration, Posters 1022-1253

About the American Society of Human Genetics (ASHG)

Founded in 1948, the American Society of Human Genetics is the primary professional membership organization for human genetics specialists worldwide. Its nearly 8,000 members include researchers, academicians, clinicians, laboratory practice professionals, genetic counselors, nurses, and others with an interest in human genetics. The Society serves scientists, health professionals, and the public by providing forums to: (1) share research results through the ASHG Annual Meeting and in The American Journal of Human Genetics; (2) advance genetic research by advocating for research support; (3) educate current and future genetics professionals, health care providers, advocates, policymakers, educators, students, and the public about all aspects of human genetics; and (4) promote genetic services and support responsible social and scientific policies. For more information, visit:

9650 Rockville Pike | Bethesda, MD 20814 | 301.634.7300 | |

Connect with ASHG on Twitter (@GeneticsSociety) | Facebook | LinkedIn

ASHG uses cookies to provide you with a secure and custom web experience. Privacy Policy